Guardant Health Inc (GH) Stock Price, Quote & News

Company Profile

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling t...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 855 698 8887

Fax: 888 974 4258

Website: guardanthealth.com

Address:

3100 Hanover Street, Palo Alto, United States

Joker83 May. 17 at 11:19 AM

$MDXH $GH $NTRA $PSNL $MDXH

0 · Reply

Joker83 May. 17 at 11:18 AM

$MDXH $GH $NTRA $PSNL $MDXH

0 · Reply

GlobalMarketBulletin May. 17 at 10:10 AM

$GH Guardant Health is making noise in precision oncology after reporting 48% revenue growth and explosive screening revenue momentum. Here’s why GH stock could be one of the most interesting healthcare growth stocks under $100. https://globalmarketbulletin.com/heres-why-guardant-health-gh-may-be-a-high-growth-biotech-stock-to-watch/

0 · Reply

GlobalMarketBulletin May. 17 at 9:49 AM

$ACGL $GH $MCHP $CCI $VTR Not every exciting stock has to trade above $500. These 10 cheap large-cap stocks under $100 include companies with fresh growth stories, improving financial results, AI partnerships, shareholder returns, and sector-specific catalysts that could make them worth watching in today’s stock market. https://globalmarketbulletin.com/top-10-cheap-large-cap-stocks-under-100-to-buy-now/

0 · Reply

Jaxtyn1989 May. 15 at 7:40 PM

$MDXH like a said, just some volume can push it to $1 and then $1.5 and all the way to $3 could be possible! $GH $NTRA $PSNL check out $MDXH

0 · Reply

Jaxtyn1989 May. 15 at 5:14 PM

$MDXH $GH $NTRA $PSNL Check $MDXH out, it has great potentials and analyst estimates to reach $5!

0 · Reply

Pavie99 May. 14 at 12:42 AM

$GH whats more overpriced...this or $NTRA

1 · Reply

Gator5326 May. 13 at 1:54 PM

$GH As of May 2026, Guardant Health (GH) stock is experiencing strong bullish sentiment with multiple price target increases following Q1 2026 results that showed 48% year-over-year revenue growth. Analysts have raised targets to a range of $130–$180, indicating a potential 29%-47% upside driven by strong oncology test volumes and Shield screening momentum.

0 · Reply